B | SE B | β | p | sr2 | |
---|---|---|---|---|---|
a) Estimated social costs | |||||
Step 1 | |||||
Constant | 0.71 | 9.24 | .938 | ||
LSAS-SR pre | 0.65 | 0.13 | .56 | <.001 | .31 |
Step 2 | |||||
Constant | 18.07 | 8.88 | .042 | ||
LSAS-SR pre | 0.47 | 0.12 | .40 | <.001 | .15 |
SCQ Δ | −0.41 | 0.08 | −.52 | <.001 | .24 |
Step 3 | |||||
Constant | 31.38 | 10.54 | .003 | ||
LSAS-SR pre | 0.47 | 0.12 | .41 | <.001 | .15 |
SCQ Δ | −0.41 | 0.34 | −.52 | .224 | .02 |
Treatment | −9.01 | 4.59 | −.42 | .051 | .04 |
SCQ Δ × treatment | 0.03 | 0.19 | .06 | .894 | .00 |
b) Self-focused attention | |||||
Step 1 | |||||
Constant | 0.71 | 9.24 | .938 | ||
LSAS-SR pre | 0.65 | 0.13 | .56 | <.001 | .31 |
Step 2 | |||||
Constant | 2.30 | 8.81 | .794 | ||
LSAS-SR pre | 0.64 | 0.13 | .55 | <.001 | .30 |
FAQ Δ | −1.41 | 0.70 | −.26 | .044 | .07 |
Step 3 | |||||
Constant | 24.68 | 10.86 | .023 | ||
LSAS-SR pre | 0.59 | 0.13 | .51 | <.001 | .23 |
FAQ Δ | −0.33 | 1.97 | −.06 | .867 | .00 |
Treatment | −13.39 | 4.46 | −.62 | .003 | .10 |
FAQ Δ × treatment | −0.74 | 1.40 | −.20 | .598 | .00 |
c) Self-efficacy | |||||
Step 1 | |||||
Constant | 0.71 | 9.24 | .938 | ||
LSAS-SR pre | 0.65 | 0.13 | .56 | <.001 | .31 |
Step 2 | |||||
Constant | 13.43 | 9.70 | .166 | ||
LSAS-SR pre | 0.57 | 0.13 | .49 | <.001 | .23 |
SESS Δ | 0.73 | 0.24 | .34 | .003 | .11 |
Step 3 | |||||
Constant | 30.13 | 12.01 | .012 | ||
LSAS-SR pre | 0.52 | 0.13 | .45 | <.001 | .16 |
SESS Δ | 0.15 | 0.85 | .07 | .857 | .00 |
Treatment | −12.73 | 4.43 | −.59 | .004 | .09 |
SESS Δ × treatment | 0.33 | 0.51 | .26 | .517 | .01 |
d) Final model | |||||
Step 1 | |||||
Constant | 0.71 | 9.24 | .938 | ||
LSAS-SR pre | 0.65 | 0.13 | .56 | <.001 | .31 |
Step 2 | |||||
Constant | 16.74 | 9.15 | .068 | ||
LSAS-SR pre | 0.48 | 0.12 | .41 | <.001 | .15 |
SCQ Δ | −0.34 | 0.12 | −.43 | .001 | .09 |
FAQ Δ | −0.59 | 0.68 | −.11 | .438 | .01 |
SESS Δ | −0.02 | 0.31 | −.01 | .825 | .00 |